Eisana Health

Reducing permanent nerve damage from chemotherapy

https://wefunder.com/eisana.health

Total raised on Wefunder: 57461

Total investors: 30

Quick facts

  • 2025 American Cancer Society BrightEdge Entrepreneur
  • Completed functional prototype
  • Completed Usability Study in humans
  • Developed only mobile device that allows functionality in hands and feet while cooling
  • Filed several patents in the US and selected countries
  • Received $400k SBIR Contract from the National Cancer Institute to specifically develop this device
  • Founder and team each have decades of relevant experience
  • Large market - 500,000 US cancer patients per year need this device

Team profiles

Featured investor profiles

Invest in Eisana Health

Reducing permanent nerve damage from chemotherapy

$288,461

of a $1,200,000 goal
INVESTMENT TERMS
Convertible Note
$8M valuation cap 8% interest 20% discount

What Investors Say

LEAD INVESTOR
Invested $25,000 this round
I am very excited to be an investor in Eisana Health because of their potential to help hundreds of thousands of cancer patients live a better life after treatment. Eisana Health is uniquely poised to revolutionize cancer care by helping patients prevent the permanent and painful nerve damage that common chemotherapy drugs cause. This is a unique opportunity to directly invest in a company that could spare you or a loved one from a permanent disability in the future.
What People Say